Skip to main content

MARSHALL WACE, LLP

Position in IMUX — Immunic, Inc.

CIK 1318757 LONDON, X0

Position in IMUX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,057,791
+$513,121 QoQ
Shares Held
952,966
-6.6% QoQ
Ownership
7.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,756,303,735 across 280 Biotechnology names. IMUX ranks #188 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMUX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,057,791 952,966
2025-12-31 $544,670 1,019,983
2025-09-30 $470,559 533,515
2025-06-30 $34,893 49,991
2025-03-31 $614,261 563,543
2024-12-31 $417,883 417,883
2024-09-30 $769,373 466,287
2024-06-30 $43,979 39,621
2024-03-31 $65,378 49,529
2023-12-31 $28,918 19,279
2023-09-30 $280,555 190,854
2023-03-31 $200,343 134,459
2022-12-31 $136,480 97,486
2022-09-30 $77,018 24,373
2021-12-31 $23,274 2,432